Literature DB >> 6817376

A statistical model for the classification of imipramine response in depressed inpatients.

R D Gibbons, D C Clark, J M Davis.   

Abstract

We present a statistical model, recently developed for application in mathematical economics, that yields empirical evidence for the existence of two distinct subtypes of depression. We reanalyze previously reported data on 65 depressed patients treated with imipramine and repeatedly rated on the Hamilton Rating Scale (HRS). The estimated model parameters suggest two underlying response processes. Patients in the first subgroup were initially more severely depressed (as measured by the total HRS score), but exhibited a rapid rate of symptomatic response over time. In contrast, patients in the second subgroup were initially less severely depressed, yet showed a much slower rate of improvement. These findings recommend a refinement of the clinical definitions of endogenous depression. While this model suggests that there are two underlying response processes, it does not classify individual patients. Subject classification was made possible by fitting an item-response model to the data. This model relates the 17 individual symptom ratings, at baseline, to the total post-treatment HRS scores. The results of this analysis suggest that the previously described relationship between high initial severity of depression and more rapid improvement over time is characteristic of subjects who exhibit initial motor retardation and decreased sexual interest. Graphical analysis clearly indicates that subjects who exhibit both motor retardation and decreased sexual interest at baseline have higher total HRS scores at baseline and show more pronounced improvement in total HRS scores in response to treatment with imipramine. Patients not exhibiting motor retardation and decreased sexual interest were less severely depressed initially and show virtually no clinical response over time.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6817376     DOI: 10.1007/bf00432260

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  AMITRIPTYLINE IN DEPRESSIVE STATES: PHENOMENOLOGY AND PROGNOSTIC CONSIDERATIONS.

Authors:  A HORDERN; N F HOLT; C G BURT; W F GORDON
Journal:  Br J Psychiatry       Date:  1963-11       Impact factor: 9.319

2.  THE DIAGNOSIS OF DEPRESSIVE SYNDROMES AND THE PREDICTION OF E.C.T. RESPONSE.

Authors:  M W CARNEY; M ROTH; R F GARSIDE
Journal:  Br J Psychiatry       Date:  1965-08       Impact factor: 9.319

3.  ELECTROCONVULSIVE THERAPY AND DEPRESSION. I. THE PROGNOSTIC SIGNIFICANCE OF CLINICAL FACTORS.

Authors:  J MENDELS
Journal:  Br J Psychiatry       Date:  1965-08       Impact factor: 9.319

4.  Prognostic factors in electric convulsive therapy.

Authors:  R F HOBSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1953-11       Impact factor: 10.154

5.  Prognostic Factors in Treatment of Depressive States with Imipramine.

Authors:  L G Kiloh; J R Ball; R F Garside
Journal:  Br Med J       Date:  1962-05-05

6.  Treatment of depression by drugs and psychotherapy.

Authors:  G L Klerman; A Dimascio; M Weissman; B Prusoff; E S Paykel
Journal:  Am J Psychiatry       Date:  1974-02       Impact factor: 18.112

7.  Predictors of amitriptyline response in outpatient depressives.

Authors:  R W Downing; K Rickels
Journal:  J Nerv Ment Dis       Date:  1972-04       Impact factor: 2.254

8.  Depression and Newcastle scales. Their relationship to Hamilton's scale.

Authors:  M W Carney; B F Sheffield
Journal:  Br J Psychiatry       Date:  1972-07       Impact factor: 9.319

9.  "Endogenous" and "neurotic" syndromes of depression: a 5- to 7-year follow-up of 104 cases.

Authors:  D W Kay; R F Garside; J R Roy; P Beamish
Journal:  Br J Psychiatry       Date:  1969-04       Impact factor: 9.319

10.  The independence of neurotic depression and endogenous depression.

Authors:  L G KILOH; R F GARSIDE
Journal:  Br J Psychiatry       Date:  1963-07       Impact factor: 9.319

  10 in total
  2 in total

1.  Evaluation of the DSM-IV and ICD-10 criteria for depressive disorders in a community population in Japan using item response theory.

Authors:  Mari Saito; Noboru Iwata; Norito Kawakami; Yutaka Matsuyama; Yutaka Ono; Yoshibumi Nakane; Yoshikazu Nakamura; Hisateru Tachimori; Hidenori Uda; Hideyuki Nakane; Makoto Watanabe; Yoichi Naganuma; Toshiaki A Furukawa; Yukihiro Hata; Masayo Kobayashi; Yuko Miyake; Tadashi Takeshima; Takehiko Kikkawa
Journal:  Int J Methods Psychiatr Res       Date:  2010-12       Impact factor: 4.035

2.  Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants.

Authors:  P Bech; P Allerup; N Reisby; L F Gram
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.